(Q34056678)

30 July 2017

1 reference

title

Gene therapy for brain tumors: the fundamentals (English)

1 reference

30 July 2017

0 references

1 reference

Engelhard HH

1

1 reference

PubMed ID

11024501

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

54

1 reference

30 July 2017

1

1 reference

30 July 2017

3-9

1 reference

Gene therapy for malignant gliomas

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Lentiviral vectors--the promise of gene therapy within reach?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene therapy for brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Urokinase antisense oligodeoxynucleotides as a novel therapeutic agent for malignant glioma: in vitro and in vivo studies of uptake, effects and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Targeting in gene therapy for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

p53 and brain tumors: from gene mutations to gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Antisense oligonucleotides for central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Adenovirus-mediated p53 gene therapy for human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene-Directed Enzyme Prodrug Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Multicolumn infusion of gene therapy cells into human brain tumors: technical report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene therapy of malignant glioma: recent advances in experimental and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene transfer technologies for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2800%2900234-2

7 January 2021

10.1016/S0090-3019(00)00234-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11024501